Lungesygdomme

Lungesygdomme is a rare genetic disorder characterized by the progressive degeneration of lung tissue, leading to respiratory failure. It is caused by mutations in the SF3B1 gene, which encodes a protein involved in RNA splicing. The disease typically presents in early childhood, with symptoms including recurrent respiratory infections, cough, and shortness of breath. Over time, lung function deteriorates, and patients may require mechanical ventilation and respiratory support.

The prognosis for lungesygdomme is generally poor, with most patients not surviving beyond their third decade. There is no known cure for the disease, and treatment is primarily supportive, focusing on managing symptoms and preventing complications. Research into potential therapies, such as gene therapy and small molecule inhibitors, is ongoing but has not yet yielded effective treatments.

Lungesygdomme is a diagnosis of exclusion, meaning it is made after other causes of lung disease have been ruled out. Diagnosis is typically confirmed through genetic testing, which identifies the characteristic mutations in the SF3B1 gene. Early diagnosis is crucial for managing symptoms and providing supportive care.

The prevalence of lungesygdomme is unknown, as it is a rare disorder. It is estimated to affect fewer than 1 in 100,000 individuals. The condition is inherited in an autosomal recessive manner, meaning both copies of the SF3B1 gene must contain mutations for the disease to develop. Affected individuals typically have no family history of the disease, as the mutations are usually de novo, occurring for the first time in the affected individual.